Author:
Ingerslev J.,Sneppen O.,Hvid I.,Knudsen L.,Thykjaer H.,Fredberg U.,Sindet-Petersen S.
Publisher
Springer Berlin Heidelberg
Reference5 articles.
1. Samsjödin L, Heijnen L, Mauser-Bunschoten E et al. (1981) Effect of activated prothrombin complex concentrate ( FEIBA) on joint and muscle bleeding in patients with haemophilia A and antibodies to factor VIII. N Engl J Med 305: 717–721
2. Chavin SI, Siegel DM, Roccota Jr et al (1988) Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor. Am J Med 85: 245
3. Ingerslev J, Sneppen O, Knudsen L, Sindet-Petersen S (1994) Efficacy of recombinant factor Vila (rFVIIa) in surgical procedures in haemophilia A patients with inhibitors and congenital factor VII deficiency. In: Scharrer I, Schramm W (eds) 24. Hämophilie Symposion, Hamburg 1993. Springer, Berlin Heidelberg New York, pp 122–125
4. Ingerslev J, Freidman D, Gastineau D, Gilchrist G, Johnsson H, Lucas G, McPherson J, Preston E, Scheibel E, Shuman M (1996) Major surgery in haemophilic patients with inhibitors using recombinant factor VIIa. Haemostasis 26 (51): 118–123
5. Schulman S, Bech Jensen M et al Feasibility of using recombinant factor VIIa in continuous infusion. Thromb haemostas 75: 432